The Schwab U.S. Dividend Equity ETF is a passively managed exchange-traded fund that seeks to track the total return of the Dow Jones U.S. Dividend 100 Index. The underlying index screens for U.S. companies with established dividend records and ranks candidates using measures of cash flow, profitability, yield, and dividend growth. The fund generally invests at least 90% of its net assets in stocks included in the index.
SCHD held about 103 stocks as of mid-2026, with top positions that have recently included Abbott Laboratories (ABT), Amgen (AMGN), Merck (MRK), Coca-Cola (KO), UnitedHealth Group (UNH), Home Depot (HD), Procter & Gamble (PG), Chevron (CVX), Verizon Communications (VZ), and PepsiCo (PEP). Sector allocation is anchored in health care and consumer staples—each roughly 20% of assets—followed by energy, industrials, financials, information technology, consumer discretionary, and communication services. Utilities represent only a marginal weight.
The fund’s 0.06% expense ratio and approximately $100 billion in assets under management make it one of the largest and lowest-cost dividend-focused ETFs. This structure produces a value-and-income portfolio: the index emphasizes current income and financial strength rather than high-growth technology leadership, which helps explain the fund’s relatively measured, dividend-supported return pattern. I also checked this using Tickeron’s AI Screener to see how the holdings compare across similar dividend strategies.
The market environment around SCHD has been defined by rotation rather than a single dominant theme. Mega-cap technology and artificial intelligence leadership cooled in mid-2026, while value, energy, and income-oriented segments attracted more attention. Longer-term Treasury yields have stayed elevated, with the 10-year yield near 4.7%, making dividend-paying equities compete more directly with bonds for investor capital.
Inflation has remained above the Federal Reserve’s long-term objective, and the central bank has maintained a cautious, data-dependent stance. That backdrop has supported cash-generative sectors with pricing power, including parts of health care, consumer staples, and energy. Energy exposure has been a particularly important swing factor: firm crude prices and geopolitical risk in the Middle East have supported upstream earnings, while short-term oil price pullbacks have periodically weighed on the sector.
Health care and consumer staples—SCHD’s largest sector blocks—have offered relatively steady demand and strong balance sheets. Financials have benefited from higher interest margins, while utilities and real estate, two rate-sensitive income groups, have faced more pressure. SCHD’s near-zero utility allocation has limited that drag.
Through mid-August 2026, SCHD rose about 6.7% over the trailing month, moving from roughly $32.34 to $34.52 based on closing prices. The advance was gradual, with the fund establishing higher lows rather than a sharp vertical move. Over the trailing three months, the fund gained approximately 8.6%, extending a broad advance from mid-May.
The fund’s recent performance reflects its sector mix. Energy, industrials, and information technology holdings delivered strong year-to-date contributions into mid-2026, while health care and financials improved over the latest three-month stretch. Consumer staples have provided steadier, less dramatic performance. Because SCHD is underweight mega-cap technology relative to the broad market, it has not fully captured AI-led rallies; however, that same structure has made its returns less dependent on a narrow group of growth stocks and more tied to earnings durability, dividends, and valuation.
For the remainder of 2026, the most important factors for SCHD are likely to be monetary policy and the direction of long-term yields. If inflation remains sticky and the Federal Reserve keeps policy restrictive, dividend equities will face continued competition from fixed income; if rate expectations ease, income-oriented stocks may become relatively more attractive.
Energy prices, Middle East supply risks, and the earnings trajectory of large integrated oil holdings will remain key swing factors. Health care policy, drug pricing headlines, and the resilience of managed care and pharmaceutical earnings will influence the fund’s largest sector exposure. Consumer staples companies must demonstrate that pricing power and input costs remain manageable.
Investors should also monitor dividend ETF flows, value-versus-growth rotation, and the payout growth of major holdings. Risks include an economic slowdown that pressures cyclical energy and financials, a sharp rise in long-term rates, or a return to narrow mega-cap technology leadership that leaves dividend-oriented portfolios lagging. No single catalyst is likely to dominate; the fund’s path will depend on the balance among these themes.
In my own workflow, I occasionally turn to Tickeron’s AI Screener when comparing dividend ETFs like SCHD against peers. The platform lets users apply technical indicators, fundamentals, volatility measures, and AI-generated signals to scan and filter thousands of securities efficiently. It has helped me surface comparable holdings and assess sector momentum without manual data crunching. Explore the AI Screener to refine your ETF and equity research workflow.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SCHD advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 372 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
SCHD broke above its upper Bollinger Band on August 19, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue